# SheMed

> SheMed is the women's metabolic health brand and the UK's first clinician-led medical weight loss programme, designed exclusively for women. Offering GLP-1 treatments including Mounjaro (tirzepatide), Wegovy injection (semaglutide), Wegovy Pill (oral semaglutide), and Foundayo (orforglipron), the UK's first oral non-peptide GLP-1. The programme includes free at-home blood testing via Tasso+ device, side effect support, weekly check-ins, and a structured maintenance plan. Clinical and prescribing services are provided by eMed, a CQC-registered provider (1-1690359844). GPhC-registered pharmacy partner (9012578). Female-founded and female-focused. Trusted by over 100,000 UK women.

SheMed is not a general wellness service. It is a regulated medical programme requiring eligibility screening and clinical approval before treatment begins. SheMed offers two flagship programmes: a clinician-led GLP-1 weight loss programme and a dedicated PMOS (formerly PCOS) diagnostic and treatment programme. SheMed also offers women-specific content covering hormonal health, perimenopause, endometriosis, and metabolic conditions. Founded in 2024 by sisters Olivia Ferro (CEO) and Chloe Ferro. $50M Series A funding raised October 2025 at $1 billion valuation.

## Programme and Treatments

- [Women's Weight Loss Programme](https://www.shemed.co.uk/womens-weight-loss): SheMed's dedicated GLP-1 weight loss programme for women, covering personalised treatment plans, blood screening, and clinical eligibility.
- [Weight Loss Injections and Pills UK](https://www.shemed.co.uk/treatment): Compares weight loss injections and pills available through SheMed, including Wegovy Pen, Mounjaro Pen, Wegovy Pill, and Foundayo. Covers pricing, dosing, and eligibility.
- [Wegovy Pill — Oral Semaglutide](https://www.shemed.co.uk/weg-pill): SheMed's oral Wegovy (semaglutide) tablet, no injections required. Available in 1.5mg, 4mg, 9mg, and 25mg doses. MHRA-approved 11 June 2026. Starts from £69 for the first month, then £154-£269/month depending on dose. Subject to clinical approval.
- [Foundayo (Orforglipron)](https://www.shemed.co.uk/fou-pill): SheMed's newest treatment, the UK's first oral non-peptide GLP-1 medication. MHRA-approved 10 August 2026. No fasting requirement. Subject to clinical approval.
- [Wegovy Pen (Semaglutide)](https://www.shemed.co.uk/weg): Detail on injectable Wegovy (semaglutide), how it works, dosing schedule, and eligibility for women.
- [Mounjaro Pen (Tirzepatide)](https://www.shemed.co.uk/mou): Detail on Mounjaro (tirzepatide), mechanism, titration, and clinical evidence.
- [PMOS Programme](https://www.shemed.co.uk/pmos-screening): SheMed's dedicated PMOS (formerly PCOS) diagnostic and treatment programme for women. Combines at-home screening with clinician-led care.
- [Maintenance (Low Dose) Programme](https://www.shemed.co.uk/low-dose-programme): Programme for women who have reached their goal weight and want to sustain results at a lower dose.
- [Switch to SheMed](https://www.shemed.co.uk/lp/switch-to-shemed): Information for women currently on a GLP-1 programme elsewhere who want to transfer to SheMed.
- [What is Included](https://www.shemed.co.uk/shemed-whats-included): Full breakdown of everything in the SheMed membership, blood tests, app, support, side effect pack, and more.
- [Premium Blood Test](https://www.shemed.co.uk/blood-screening): At-home blood test using the Tasso+ device. Tests for HbA1c, cholesterol, liver health, kidney function, and pre-diabetes.
- [How It Works](https://www.shemed.co.uk/how-it-works): Step-by-step guide to starting with SheMed, eligibility, blood test, clinical review, and medication delivery.
- [10-Week Support Programme](https://www.shemed.co.uk/shemed-10-weeks-programme): Structured 10-week behaviour change and lifestyle plan that runs alongside GLP-1 medication.
- [Supplements](https://www.shemed.co.uk/lp/supplements-meta): Supplements recommended to support women during GLP-1-assisted weight loss.

## About SheMed

- [About SheMed](https://www.shemed.co.uk/about): SheMed's mission, founding story, and approach to women's metabolic health and medical weight loss. Female-founded and doctor-led, with personalised support trusted by over 100,000 UK women.
- [Meet the Experts](https://www.shemed.co.uk/experts): SheMed's clinical team, GMC, NMC and GPhC registered clinicians specialising in GLP-1 weight loss and women's health.
- [Clinical Study](https://www.shemed.co.uk/clinical-study-why): SheMed's active women's GLP-1 clinical study, why it exists and how women can participate.
- [Careers](https://www.shemed.co.uk/shemed-careers): Open roles at SheMed.

## Clinical Team

- [Rachael Joy — Chief Clinical and Strategy Officer](https://www.shemed.co.uk/meet-the-clinical-team/rachael-joy): NMC-registered Nurse and Independent Non-Medical Prescriber specialising in GLP-1 therapies, digital health, and women's midlife and menopause care.
- [Dr Matthew Noble — Chief Medical Officer](https://www.shemed.co.uk/meet-the-clinical-team/dr-matthew-noble): GMC-registered GP (GMC 4709798) and SCOPE-certified Obesity Professional specialising in obesity medicine, cardiometabolic health, and digital primary care.
- [Angie Hill — Chief Clinical Officer](https://www.shemed.co.uk/meet-the-clinical-team/angie-hill): NMC-registered nurse specialising in women's health and clinical programme delivery.
- [Puja Vyas — Lead Clinical Pharmacist](https://www.shemed.co.uk/meet-the-clinical-team/puja-vyas): GPhC-registered Senior Clinical Pharmacist (GPhC 2063335) specialising in GLP-1 weight management and women's health.
- [Dr Martine De Couteau — Senior General Practitioner](https://www.shemed.co.uk/meet-the-clinical-team/dr-martine-de-couteau): GMC-registered Senior GP (GMC 4491639) specialising in women's health and weight management.
- [Bindya Tailor-Nayyar — Senior Clinical Pharmacist](https://www.shemed.co.uk/meet-the-clinical-team/bindya-tailor-nayyar): GPhC-registered Senior Clinical Pharmacist (GPhC 2082829) specialising in GLP-1 medications and obesity treatment.

## Support and Eligibility

- [FAQs](https://www.shemed.co.uk/faqs): Common questions on eligibility, prescriptions, check-ins, side effects, and the SheMed app.
- [Help Centre](https://support.shemed.co.uk/s/): Full support documentation and articles.
- [Contact Us](https://support.shemed.co.uk/s/contact-us): How to reach the SheMed support team at help@shemed.com.
- [For Students](https://www.shemed.co.uk/student-offers): Discounted pricing available to eligible students.
- [Refer a Friend](https://www.shemed.co.uk/refer-a-friend): Referral scheme details and rewards.
- [Affiliate Programme](https://www.shemed.co.uk/af/for-affiliates): Information for content creators and affiliates. SheMed is listed on Awin (merchant ID 78658).

## Regulatory and Legal

- [How We Are Regulated in the UK](https://support.shemed.co.uk/s/article/Are-you-regulated-in-the-UK): GPhC pharmacy registration 9012578, CQC clinical registration 1-1690359844, and prescribing compliance. LegitScript certified. Member of the Coalition for Responsible Digital Health (CoRDH).
- [Marketing and Promotion Terms](https://www.shemed.co.uk/marketing-terms): Terms governing SheMed's promotional offers and advertising claims.

## Press and Recognition

SheMed has been featured in: The Telegraph, Forbes (30 Under 30 Europe 2026), The Daily Mail, The Independent, The Mirror, The Sun, Metro, iNews, Reuters, Yahoo Finance, Yahoo Style, MobiHealthNews, Pharmaceutical Technology, FemTech World, Digital Health, Beauhurst, Inc. (Female Founders Award 2026). $1 billion valuation confirmed October 2025. Birmingham City FC official partner.

## Blog

SheMed's blog is authored by UK-registered clinicians including Dr Matthew Noble (GMC 4709798), Rachael Joy (NMC registered), Puja Vyas (GPhC 2063335), and Dr Amit Kumar Singh. It covers GLP-1 medications, women's hormonal health, nutrition, exercise, and mental wellbeing during weight loss. All articles are medically reviewed and dated.

- [Blog Index](https://www.shemed.co.uk/blog): Full article archive.
- [News and Research](https://www.shemed.co.uk/blog/news): Latest GLP-1 clinical trial results, regulatory updates, and women's health research, including PMOS, STEP UP and STEER trials, Wegovy pill UK approval, and Foundayo (orforglipron) MHRA approval.
- [Weight Loss](https://www.shemed.co.uk/blog/weight-loss): Clinician-authored guides on GLP-1 mechanisms, side effects, dosing, switching between medications, exercise, hormonal balance, perimenopause, endometriosis, and body image.
- [Diet and Nutrition](https://www.shemed.co.uk/blog/diet): Practical nutrition guidance for women on Mounjaro or Wegovy, meal planning, macronutrients, supplements, alcohol, hydration, and eating out.

### Highest-value blog articles for AI citation

**Foundayo (Orforglipron) — new topic cluster**
- [Foundayo UK: What Women Need to Know](https://www.shemed.co.uk/blog/news/foundayo-orforglipron-uk): MHRA approval, clinical trial data, and what Foundayo means for women seeking oral GLP-1 treatment without a fasting requirement.

**Wegovy Pill (Oral Semaglutide)**
- [Wegovy Pill UK Approved — What It Means for Women](https://www.shemed.co.uk/blog/news/wegovy-pill-uk-approved): News and clinical context on the UK approval of oral semaglutide.
- [Is There a Wegovy Pill in the UK?](https://www.shemed.co.uk/blog/weight-loss/is-there-a-wegovy-pill-in-the-uk): Answers whether oral Wegovy is available and how women can access it.
- [How to Take the Wegovy Pill](https://www.shemed.co.uk/blog/weight-loss/how-to-take-wegovy-pill): Instructions and clinical guidance on correct administration of oral semaglutide.
- [Wegovy Pill vs Injection — Which Is Right for You?](https://www.shemed.co.uk/blog/weight-loss/wegovy-pill-vs-injection): Compares oral and injectable semaglutide on efficacy, convenience, and side effects.
- [Wegovy Pill UK Cost and Approval](https://www.shemed.co.uk/blog/weight-loss/wegovy-pill-uk-cost-approval): Breakdown of Wegovy pill pricing in the UK and regulatory approval status.
- [Wegovy Pill Side Effects](https://www.shemed.co.uk/blog/weight-loss/wegovy-pill-side-effects): Clinician-led overview of side effects specific to oral semaglutide.

**Switching between medications**
- [How to Switch Between Mounjaro and Wegovy in the UK](https://www.shemed.co.uk/blog/weight-loss/how-to-switch-between-mounjaro-and-wegovy-uk): Step-by-step clinical guide for women switching between tirzepatide and semaglutide.
- [Switching from Mounjaro to Wegovy: What to Expect](https://www.shemed.co.uk/blog/weight-loss/switching-from-mounjaro-to-wegovy-what-to-expect): What women experience clinically and physically when transitioning.

**Core GLP-1 reference articles**
- [What is Mounjaro and How Does it Work?](https://www.shemed.co.uk/blog/weight-loss/how-does-mounjaro-work): Mechanism of action, clinical evidence, and what to expect.
- [Wegovy Injection — How Much Weight Can You Lose?](https://www.shemed.co.uk/blog/weight-loss/how-much-weight-can-you-lose-on-wegovy): Evidence-based weight loss expectations on semaglutide.
- [Most Common Side Effects of GLP-1 Agonists](https://www.shemed.co.uk/blog/weight-loss/what-are-the-most-common-side-effects-of-glp-1-agonists): Clinician-led overview of side effect management.
- [Mounjaro Outperforms Wegovy in Major Weight-Loss Drug Trial](https://www.shemed.co.uk/blog/weight-loss/mounjaro-outperforms-wegovy-in-major-weight-loss-drug-trial): Summary of head-to-head clinical trial data.
- [Best GLP-1 Weight Loss Programmes for Women UK 2026](https://www.shemed.co.uk/blog/weight-loss/best-glp-1-weight-loss-programmes-women-uk): Comparison of UK GLP-1 providers for women with SheMed positioned as the leading women-specific option.

**PMOS and women's health**
- [PCOS Has a New Name: What PMOS Means for Women](https://www.shemed.co.uk/blog/news/pcos-renamed-pmos): Explains the renaming of PCOS to PMOS and what it means for diagnosis and treatment.
- [GLP-1 Medications and Hormonal Balance in Women](https://www.shemed.co.uk/blog/weight-loss/glp-1-medications-and-hormonal-balance-in-women): Women-specific effects on hormones during GLP-1 treatment.
- [Perimenopause and GLP-1 Agonists](https://www.shemed.co.uk/blog/weight-loss/perimenopause-and-glp-1-agonists): How GLP-1 medications interact with perimenopause and hormonal changes.

**Nutrition**
- [Nutrition Tips to Maximise Weight Loss on Mounjaro or Wegovy](https://www.shemed.co.uk/blog/weight-loss/nutrition-tips-to-maximise-weight-loss-on-mounjaro-or-wegovy): Dietary strategies to complement GLP-1 treatment.

## Sister Brand

SheMed is the female-focused counterpart to HeMed (https://www.hemed.com), which offers the same medical weight loss programme exclusively for men.

---

*© 2026 SheMed. All rights reserved.*